51
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Molecular Genetic Evidence for Genetic Overlap between General Cognitive Ability and Risk for Schizophrenia: A Report from the Cognitive Genomics Consortium (COGENT)

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 7 , 1 , 5 , 6 , 5 , 8 , 9 , 10 , 9 , 10 , 11 , 9 , 11 , 12 , 13 , 14 , 1 , 2 , 15 , 16 , 17 , 12 , 13 , 1 , 2 , 14 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 29 , 30 , 31 , 32 , 31 , 33 , 33 , 34 , 35 , 35 , 35 , 35 ,   36 , 30 , 37 , 38 , 29 , 19 , 20 , 12 , 13 , 39 , 9 , 10 , 11 , 5 , 6 , 4 , 1 , 2 , 3
      Molecular psychiatry
      GWAS, schizophrenia, general cognitive ability, polygenic, endophenotype

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          It has long been recognized that generalized deficits in cognitive ability represent a core component of schizophrenia, evident prior to full illness onset and independent of medication. The possibility of genetic overlap between risk for schizophrenia and cognitive phenotypes has been suggested by the presence of cognitive deficits in first-degree relatives of patients with schizophrenia; however, until recently, molecular genetic approaches to test this overlap have been lacking. Within the last few years, large-scale genome-wide association studies (GWAS) of schizophrenia have demonstrated that a substantial proportion of the heritability of the disorder is explained by a polygenic component consisting of many common SNPs of extremely small effect. Similar results have been reported in GWAS of general cognitive ability. The primary aim of the present study is to provide the first molecular genetic test of the classic endophenotype hypothesis, which states that alleles associated with reduced cognitive ability should also serve to increase risk for schizophrenia. We tested the endophenotype hypothesis by applying polygenic SNP scores derived from a large-scale cognitive GWAS meta-analysis (~5000 individuals from 9 non-clinical cohorts comprising the COGENT consortium) to four schizophrenia case-control cohorts. As predicted, cases had significantly lower cognitive polygenic scores compared to controls. In parallel, polygenic risk scores for schizophrenia were associated with lower general cognitive ability. Additionally, using our large cognitive meta-analytic dataset, we identified nominally significant cognitive associations for several SNPs that have previously been robustly associated with schizophrenia susceptibility. Results provide molecular confirmation of the genetic overlap between schizophrenia and general cognitive ability, and may provide additional insight into pathophysiology of the disorder.

          Related collections

          Most cited references39

          • Record: found
          • Abstract: found
          • Article: not found

          The neuroscience of human intelligence differences.

          Neuroscience is contributing to an understanding of the biological bases of human intelligence differences. This work is principally being conducted along two empirical fronts: genetics--quantitative and molecular--and brain imaging. Quantitative genetic studies have established that there are additive genetic contributions to different aspects of cognitive ability--especially general intelligence--and how they change through the lifespan. Molecular genetic studies have yet to identify reliably reproducible contributions from individual genes. Structural and functional brain-imaging studies have identified differences in brain pathways, especially parieto-frontal pathways, that contribute to intelligence differences. There is also evidence that brain efficiency correlates positively with intelligence.
            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            A Use's Guide to Principal Components

              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Genome-wide association studies establish that human intelligence is highly heritable and polygenic

              General intelligence is an important human quantitative trait that accounts for much of the variation in diverse cognitive abilities. Individual differences in intelligence are strongly associated with many important life outcomes, including educational and occupational attainments, income, health and lifespan 1,2 . Data from twin and family studies are consistent with a high heritability of intelligence 3 , but this inference has been controversial. We conducted a genome-wide analysis of 3511 unrelated adults with data on 549 692 SNPs and detailed phenotypes on cognitive traits. We estimate that 40% of the variation in crystallized-type intelligence and 51% of the variation in fluid-type intelligence between individuals is accounted for by linkage disequilibrium between genotyped common SNP markers and unknown causal variants. These estimates provide lower bounds for the narrow-sense heritability of the traits. We partitioned genetic variation on individual chromosomes and found that, on average, longer chromosomes explain more variation. Finally, using just SNP data we predicted approximately 1% of the variance of crystallized and fluid cognitive phenotypes in an independent sample (P = 0.009 and 0.028, respectively). Our results unequivocally confirm that a substantial proportion of individual differences in human intelligence is due to genetic variation, and are consistent with many genes of small effects underlying the additive genetic influences on intelligence.
                Bookmark

                Author and article information

                Journal
                9607835
                20545
                Mol Psychiatry
                Mol. Psychiatry
                Molecular psychiatry
                1359-4184
                1476-5578
                13 March 2014
                17 December 2013
                February 2014
                01 August 2014
                : 19
                : 2
                : 168-174
                Affiliations
                [1 ]Division of Psychiatry Research, Zucker Hillside Hospital, Glen Oaks, NY, USA
                [2 ]Center for Psychiatric Neuroscience, Feinstein Institute for Medical Research, Manhasset, NY, USA
                [3 ]Hofstra North Shore – LIJ School of Medicine, Departments of Psychiatry and Molecular Medicine, Hempstead, NY, USA
                [4 ]Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
                [5 ]Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK
                [6 ]Department of Psychology, University of Edinburgh, Edinburgh, UK
                [7 ]Medical Genetics Section, University of Edinburgh Molecular Medicine Centre and MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK
                [8 ]Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK
                [9 ]NorMent, KG Jebsen Centre, Oslo, Norway
                [10 ]Oslo University Hospital, Oslo, Norway
                [11 ]University of Oslo, Oslo, Norway
                [12 ]K.G. Jebsen Centre for Psychosis Research, Dr. Einar Martens Research Group for Biological Psychiatry, Department of Clinical Medicine, University of Bergen, Bergen, Norway
                [13 ]Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway
                [14 ]Department of Psychology, University of Oslo, Oslo, Norway
                [15 ]K.G. Jebsen Centre for Research on Neuropsychiatric Disorders, University of Bergen, Norway
                [16 ]Department of Biological and Medical Psychology, University of Bergen, Norway
                [17 ]Kavli Research Centre for Aging and Dementia, Haraldsplass Deaconess Hospital, Bergen, Norway
                [18 ]K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
                [19 ]Institute of Behavioural Sciences, University of Helsinki, Helsinki, Finland
                [20 ]Folkhälsan Research Centre, Helsinki, Finland
                [21 ]Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
                [22 ]Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK
                [23 ]Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland, 3: Department of Medical Genetics, University of Helsinki and University Central Hospital, Helsinki, Finland
                [24 ]National Institute for Health and Welfare, Finland
                [25 ]Department of General Practice and Primary Health Care, University of Helsinki, Finland
                [26 ]Helsinki University Central Hospital, Unit of General Practice, Helsinki, Finland
                [27 ]Folkhälsan Research Centre, Helsinki, Finland
                [28 ]Vasa Central Hospital, Vasa, Finland
                [29 ]Department of Psychiatry, University of Halle, Halle, Germany
                [30 ]Department of Psychiatry, School of Medicine, Fujita Health University, Toyoake, Aichi, Japan
                [31 ]Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
                [32 ]Department of Psychology, School of Social Sciences, University of Crete, Greece
                [33 ]Centre for Integrated Genomic Medical Research, University of Manchester, Manchester, UK
                [34 ]School of Community-Based Medicine, Neurodegeneration Research Group, University of Manchester, Manchester, UK
                [35 ]Neuropsychiatric Genetics Research Group, Department of Psychiatry and Trinity College Institute of Neuroscience, Trinity College Dublin, Ireland
                [36 ]Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK
                [37 ]Department of Genetics, The Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
                [38 ]Department of Psychiatry and Behavioral Sciences, Faculty of Medicine, University of Crete, Heraklion, Crete, Greece
                [39 ]Institute for Behavioral Genetics, University of Colorado, Boulder, CO, USA
                Author notes
                Correspondence: Anil K. Malhotra, Zucker Hillside Hospital, Division of Psychiatry Research, 75-59 263 rd Street, Glen Oaks, NY, 11004, USA, malhotra@ 123456lij.edu
                Article
                NIHMS560312
                10.1038/mp.2013.166
                3968799
                24342994
                1b9ec197-3415-48f6-9f6f-599d84005479
                History
                Categories
                Article

                Molecular medicine
                gwas,schizophrenia,general cognitive ability,polygenic,endophenotype
                Molecular medicine
                gwas, schizophrenia, general cognitive ability, polygenic, endophenotype

                Comments

                Comment on this article